Press Releases

 
Press Releases
  Date Title View
Apr 2, 2015
ALBANY, N.Y., April 2, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that it has decided to close its Holywell, U.K. facility following a consultation process with employee representatives. The Holywell site provides chemical development services and small- and large scale-manufacturing services of active pharmaceutical ingredients (API)...
Mar 5, 2015
ALBANY, N.Y., March 5, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that Michael Pettersson, fills the newly created position of VP of International Sales, effective immediately. He reports to Christopher Conway, Senior Vice President of Global Sales and Marketing. In this role, Mr. Pettersson will lead the international sales t...
Feb 25, 2015
ALBANY, N.Y., Feb. 25, 2015 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at Barclays Global Healthcare Conference on Wednesday, March 11, 2015 at 2:50 PM ET. A live audio webcast of the presentation can be accessed at AMRI's Inv...
Feb 12, 2015
ALBANY, N.Y., Feb. 12, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has implemented several changes to further optimize global business operations in order to enhance continuity from early development through to commercial supply and accelerate the company's global growth objectives.  The realigned structure will continu...
Feb 12, 2015
ALBANY, N.Y., Feb. 12, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2014. "While our OsoBio facility resumed full operations later than anticipated, after we learned in the fall of 2014 that a remediation would be necessary, strong execution le...
Feb 12, 2015
Albany, NY (February 12, 2015) - AMRI (NASDAQ: AMRI) announced today its intention, subject to consultation with its UK workforce, to close its UK facility in Holywell, Wales, which provides chemical development services and small- and large-scale manufacturing services of active pharmaceutical ingredients (API). "The original strategy...
Feb 9, 2015
ALBANY, N.Y., Feb. 9, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that Jimmy Wang, Ph.D., fills the newly created position of Chief Information Officer, effective immediately. He replaces Carl Neumann, Senior Director, Information Technology, who retires this month. In this role, Dr. Wang will manage and oversee major technolog...
Jan 29, 2015
ALBANY, N.Y., Jan. 29, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year financial results before the opening of the market on Thursday, February 12, 2015.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The confer...
Jan 19, 2015
ALBANY, N.Y., Jan. 19, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it received a 10-year federal contract award from the National Institutes of Health (NIH) for drug development and manufacturing services. This NIH/National Institute of Neurological Disorders and Stroke (NINDS) award will support NIH's Drug Manufacturing and Formulatio...
Jan 12, 2015
ALBANY, N.Y., Jan. 12, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has entered into several development and supply agreements with Genovi Pharmaceuticals Limited ("Genovi"), a specialty generic pharmaceutical company, to manufacture select generic parenteral drug products for registration and subsequent commercialization in the...
Page:
1
... NextLast
= add release to Briefcase